Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Tonelli

Showing results (71-80 of 83) with videos related to

Pageof 9
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 17, 2001
Identification of cytochrome P-450 isoforms responsible for cis-tramadol metabolism in human liver microsomesV Subrahmanyam, A B Renwick, D G Walters, et al.
Calcified Tissue International|September 24, 1998
Effects of ipriflavone on perialveolar bone formationM Martini, L Formigli, P Tonelli, et al.
Journal for Immunotherapy of Cancer|December 15, 2023
Phase 2 trial of a DNA vaccine (pTVG-HP) and nivolumab in patients with castration-sensitive non-metastatic (M0) prostate cancerDouglas G McNeel, Hamid Emamekhoo, Jens C Eickhoff, et al.
Cellular Signalling|August 16, 2015
Calcium signaling and cell proliferationMauro Cunha Xavier Pinto, Alexandre Hiroaki Kihara, Vânia A M Goulart, et al.
Clinical Oral Implants Research|April 18, 2008
Immediate transmucosal implant placement in molar extraction sites: a 12-month prospective multicenter cohort studyC Cafiero, S Annibali, E Gherlone, et al.
Advances in Experimental Medicine and Biology|March 29, 2012
Stem cells and calcium signalingFernanda M P Tonelli, Anderson K Santos, Dawidson A Gomes, et al.
Journal of Chemotherapy (Florence, Italy)|July 1, 1989
Pharmacokinetics of YTR830H and piperacillin after intravenous coadministrationW K Cheung, D S Greene, O Kuye, et al.
Oncology Research|October 8, 2009
Gemcitabine plus irinotecan as first-line weekly therapy in locally advanced and/or metastatic pancreatic cancerB Neri, G Cipriani, R Grifoni, et al.
Nanomedicine (London, England)|August 6, 2015
Graphene-based nanomaterials: biological and medical applications and toxicityFernanda M P Tonelli, Vânia A M Goulart, Katia N Gomes, et al.
Cancer Chemotherapy and Pharmacology|July 28, 2010
Pharmacokinetics, efficacy and toxicity of different pegylated liposomal doxorubicin formulations in preclinical models: is a conventional bioequivalence approach sufficient to ensure therapeutic equivalence of pegylated liposomal doxorubicin products?Rao N V S Mamidi, Steve Weng, Susan Stellar, et al.
Pageof 9

Showing results (71-80 of 83) with videos related to

Sort By:
Pageof 9
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 17, 2001
Identification of cytochrome P-450 isoforms responsible for cis-tramadol metabolism in human liver microsomesV Subrahmanyam, A B Renwick, D G Walters, et al.
Calcified Tissue International|September 24, 1998
Effects of ipriflavone on perialveolar bone formationM Martini, L Formigli, P Tonelli, et al.
Journal for Immunotherapy of Cancer|December 15, 2023
Phase 2 trial of a DNA vaccine (pTVG-HP) and nivolumab in patients with castration-sensitive non-metastatic (M0) prostate cancerDouglas G McNeel, Hamid Emamekhoo, Jens C Eickhoff, et al.
Cellular Signalling|August 16, 2015
Calcium signaling and cell proliferationMauro Cunha Xavier Pinto, Alexandre Hiroaki Kihara, Vânia A M Goulart, et al.
Clinical Oral Implants Research|April 18, 2008
Immediate transmucosal implant placement in molar extraction sites: a 12-month prospective multicenter cohort studyC Cafiero, S Annibali, E Gherlone, et al.
Advances in Experimental Medicine and Biology|March 29, 2012
Stem cells and calcium signalingFernanda M P Tonelli, Anderson K Santos, Dawidson A Gomes, et al.
Journal of Chemotherapy (Florence, Italy)|July 1, 1989
Pharmacokinetics of YTR830H and piperacillin after intravenous coadministrationW K Cheung, D S Greene, O Kuye, et al.
Oncology Research|October 8, 2009
Gemcitabine plus irinotecan as first-line weekly therapy in locally advanced and/or metastatic pancreatic cancerB Neri, G Cipriani, R Grifoni, et al.
Nanomedicine (London, England)|August 6, 2015
Graphene-based nanomaterials: biological and medical applications and toxicityFernanda M P Tonelli, Vânia A M Goulart, Katia N Gomes, et al.
Cancer Chemotherapy and Pharmacology|July 28, 2010
Pharmacokinetics, efficacy and toxicity of different pegylated liposomal doxorubicin formulations in preclinical models: is a conventional bioequivalence approach sufficient to ensure therapeutic equivalence of pegylated liposomal doxorubicin products?Rao N V S Mamidi, Steve Weng, Susan Stellar, et al.
Pageof 9